The FDA has cleared RevealDx’s AI-powered lung nodule risk assessment software, RevealAI-Lung, according to a company press ...

A key outcome from lung cancer screening studies is the concept of ‘stage-shift’ seen in screen-detected cancers compared with those clinically detected. Prior to lung cancer screening, only 28% of ...

Doctor holding a blood sample in lab. science and medical concept The approach improved risk assessment compared with 2021 USPSTF screening criteria. Risk assessment for lung cancer screening can be ...

A simple online tool offered by Lung Health Foundation helps people understand their potential lung cancer risk - no medical ...

For adults with NSCLC, assessment of more than one N1 nodal station is associated with increased nodal upstaging and improved survival.

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that it has received confirmation that its Prospera Lung donor-derived ...

By Priyanjana Pramanik, MSc. Researchers reveal why lung cancer in people who never smoked is increasing and explore how ...

Ask a clinical question and tap into Healio AI's knowledge base. Lung cancer in general, and non-small cell lung cancer (NSCLC) in particular, is often asymptomatic in the early stages of the disease.

The 2021 USPSTF lung cancer screening recommendations have broadened; however, these guidelines have not been compared with other criteria or evaluated for sensitivity and specificity differences by ...

An artificial intelligence (AI)-powered tool that characterizes lung nodules has earned clearance from the FDA, according to ...